Access
This article is part of Nature's premium content.
Published online 15 April 2009 | Nature 458, 818 (2009) | doi:10.1038/458818a
News
A synthetic-biology reality check
Is the abrupt closure of prominent player Codon Devices an omen for the field?
Launched with some fanfare in 2004, Codon Devices of Cambridge, Massachusetts, was touted as a flagship for the industrial applications of synthetic biology, a nascent discipline that applies engineering approaches to the molecular design of biological systems. In late March, however, the company closed its doors.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
There are currently no comments.
